Aytu BioPharma, Inc.
Asset & Liabilities Breakdown
FY2026
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
Asset Breakdown FY2026
Total Assets: $105.0M
Liabilities Breakdown FY2026
Total Liabilities: $69.7M
Asset Breakdown
Total Assets: $105.0M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $26.3M | 25.1% |
| Accounts Receivable | $22.8M | 21.7% |
| Inventory | $6.9M | 6.5% |
| Property, Plant & Equipment | $385.0K | 0.4% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $41.4M | 39.4% |
| Other Assets | $7.3M | 6.9% |
Liabilities Breakdown
Total Liabilities: $69.7M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $11.3M | 16.2% |
| Long-Term Debt | $9.1M | 13.1% |
| Other Liabilities | $49.3M | 70.8% |